//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
ProfilePosts









Loading...
We had a wonderful few days at #Euromit2026 with many of the leading mitochondrial medicine researchers and clinicians around the world. Thanks for sharing your important work and learning about ours! #PRIZM #MELAS #MitochondrialDisease #Biosky @euromit-2026.bsky.social
Next month we’re off to #UMDF #MitoMed Conference, which provides an opportunity for researchers & drug developers like us to meet patients & families. These interactions are critical for meaningful innovation, enabling deeper understanding of lived experiences. #WeHearYou #Biosky
Check out this #Rareatives interview with our VP of Clinical Research, Chad Glasser! He discusses patient-informed #RareDisease trials, the recent #MELAS EL-PFDD meeting led by #MitoAction, and the completion of enrollment in our Ph2b PRIZM study. #Biosky rareatives.com/2026/04/29/t...
Learnings from #RareDisease #ClinicalDevelopment are shaping the future of medicine– from sharpened trial design discipline and innovation to deepened collaborations with patients, families, and other stakeholders around the world. #WeHearYou #Biosky www.the-scientist.com/what-rare-di...
Bonjour, Angers! #Euromit2026 starts in two days, and we are energized! Visit us at our booth to learn more about our clinical program in #MitochondrialDisease, including our fully enrolled Phase 2b PRIZM study in #MELAS. #WeHearYou #Biosky @euromit-2026.bsky.social
8d
It’s #BrainAwarenessWeek! Many #MitochondrialDiseases can have negative implications for brain health. That’s because the brain requires a massive amount of energy, which can only be sufficiently produced when mitochondria are functioning well. #UMDF #Biosky
There are 6,000+ rare diseases—and expertise and information are often scarce. In health systems designed for common diseases, rare diseases often face inequities. download2.rarediseaseday.org/2025/campaig... #RareDiseaseDay #HealthEquity #MitochondrialDisease #MELAS #Biosky
Looking forward to #Euromit2026 this month! As a Silver Sponsor, we’re proud to support 5 days of cutting-edge science and networking among those committed to improving outcomes for people with #MitochondrialDiseases like #MELAS. @euromit-2026.bsky.social #Biosky www.euromit2026.eu/program-over...
17d
1mo
@tisentotx.bsky.social is proud to support #euromit2026 as a Silver Sponsor! Our clinical program in the rare #MitochondrialDisease #MELAS is evaluating zagociguat’s effect on symptoms that matter most to patients—including fatigue and cognitive dysfunction. Visit our booth at #Euromit2026#WeHearYou
3mo
14d
Today is #RareDiseaseDay. We stand with the 300 million people globally who live with a rare disease, including those with rare #MitochondrialDiseases like #MELAS. Read stories of #RareDisease heroes: www.rarediseaseday.org/heroes/ #Biosky
2mo
3mo
25d
2mo
3mo
The Official Campaign Video of Rare Disease Day 2026- Learn more and get involved! šŸ‘‰ https://www.rarediseaseday.org/
youtu.be
Rare Disease Day 2026 Official Video
Tisento Therapeutics
Tisento Therapeutics
Tisento Therapeutics
Tisento Therapeutics
Tisento Therapeutics
Tisento Therapeutics
Tisento Therapeutics
Tisento Therapeutics
Tisento Therapeutics
Euromit-2026